Differences in tumor-to-normal organ SUV ratios measured with 68Ga-DOTATATE PET compared with 177Lu-DOTATATE SPECT in patients with neuroendocrine tumors-Reference-Cited by-同舟云学术

Differences in tumor-to-normal organ SUV ratios measured with 68Ga-DOTATATE PET compared with 177Lu-DOTATATE SPECT in patients with neuroendocrine tumors

Published:2022-06-10 Issue:8 Volume:43 Page:892-900
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Wong Ka Kit,Frey Kirk A.,Niedbala Jeremy,Kaza Ravi K.,Worden Francis P.,Fitzpatrick Kellen J.,Dewaraja Yuni K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference23 articles.

1. Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors.;Strosberg;N Engl J Med,2017

2. NANETS/SNMMI Procedure standard for somatostatin receptor-based peptide receptor radionuclide therapy with (177)Lu-DOTATATE.;Hope;J nucl med: official publication, Soc Nucl Med,2019

3. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours.;Bodei;Eur J Nucl Med Mol Imaging,2013

4. Integrating early rapid post-peptide receptor radionuclide therapy quality assurance scan into the outpatient setting.;Mahajan;J Nucl Med Radiat Ther,2019

5. Does the pretherapeutic tumor SUV in 68Ga DOTATOC PET predict the absorbed dose of 177Lu octreotate?;Ezziddin;Clin Nucl Med,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the dosimetry of scandium-43 and scandium-44 patient organ doses in relation to commonly used gallium-68 for imaging neuroendocrine tumours;EJNMMI Physics;2024-07-15

2. The Impact of Posttreatment Imaging in Peptide Receptor Radionuclide Therapy;Journal of Nuclear Medicine;2024-03

3. A radiomic‐ and dosiomic‐based machine learning regression model for pretreatment planning in ¹⁷⁷Lu‐DOTATATE therapy;Medical Physics;2023-09-18

4. The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry;European Journal of Nuclear Medicine and Molecular Imaging;2023-05-12

5. 177Lu-DOTATATE Theranostics;Clinical Nuclear Medicine;2023-02-08